Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol-Enhanced MRI for Bone Sarcomas and Osteomyelitis
NCT01336803Phase 2Completed
- Start
- Aug 2011
- Primary completion
- Jul 2014
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of ferumoxytol in bone sarcoma and osteomyelitis (OM) (2 arms). Primary endpoint: T2* Relaxation Time of Bone Sarcomas and Osteomyelitis Subjects at 24 hours. Started Aug 2011; status: completed.
02
Drugs
ferumoxytol
03
Conditions
bone sarcomaosteomyelitis (OM)
Beyond the preview
Go deeper on NCT01336803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01336803.